ACRS compared with IPSC: revenue, margins and what each company keeps, and the suppliers and customers both name

ACRSAclaris Therapeutics, Inc.

Mkt capRevenueRevenue

IPSCCentury Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

ACRSAclaris Therapeutics, Inc.

IPSCCentury Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ACRS 5

LLYEli Lillycustomer

—Biosionunlistedsupplier

—Pediatrix Therapeuticsunlistedcustomer

—Sun Pharmaceutical Industriesunlistedcustomer

1 more · ACRS chain ›

Shared 0

No shared counterparties.

Only IPSC 7

BMYBristol-Myers Squibbcustomer

—FUJIFILM Cellular Dynamicsunlistedsupplier

—Catalent Dusseldorf GmbHunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Fcdi

unlistedsupplier

3 more · IPSC chain ›

ACRSAclaris Therapeutics, Inc.

3.80▼−4.32%· post 3.80· delayed

Mkt cap$584.4MRevenue$2MQ2 FY26Revenue$8MFY25

IPSCCentury Therapeutics, Inc.

1.470.00%· delayed

After hoursNov 2 '26delayed

Mkt cap$266.2MRevenue$109MQ1 FY25Revenue$7MFY24

Compare

After hoursNov 2 '26delayed

ACRSAclaris Therapeutics, Inc.

IPSCCentury Therapeutics, Inc.

3.80▼−4.32%post 3.80delayed

Price

1.470.00%delayed

$584.4M

Mkt cap

$266.2M

Q2 FY26$2M

Revenue

$109MQ1 FY25

FY25$8M

Revenue

$7MFY24

ACRS3.80▼−4.32%vsIPSC1.470.00%After hoursNov 2 '26delayed